Immunoassays: Page 3

Beckman Coulter Diagnostics announces global launch of immunoassay analyzer

By LabPulse.com staff writers

The analyzer can run up to 215 tests per hour per square meter and, according to Beckman Coulter Diagnostics, beta users attest to a feature that redefines their workday with no daily maintenance requirements.

May 15, 2023

OraSure Technologies Q1 revenues up 129% on COVID-19 rapid immunoassay sales

By Leo O'Connor

Demand for rapid tests is tapering, and OraSure is scaling-down COVID-19 test manufacturing amid staff layoffs.

May 11, 2023

AACC releases guidance on procalcitonin testing for patients with bacterial infections

By LabPulse.com staff writers

Procalcitonin tests have been used for many years in Europe, but only became available in the U.S. in 2017, when the FDA approved them as tools to help guide antibiotic treatment, among other uses.

May 5, 2023

Meridian Bioscience receives FDA clearance for Shiga toxin assay

By LabPulse.com staff writers

Meridian Bioscience is expanding its foodborne immunofluorescent test offering by adding Shiga toxin to the Curian platform.

April 20, 2023

Renalytix announces review data on kidney disease risk assessment test

By Maryam Payne

A review of the data underscored the effectiveness of KidneyIntelX in identifying patients at greatest risk of decline into kidney failure at the earlier stages, when progression can be slowed.

April 19, 2023

Audere receives $9.35M grant to develop RDT results interpretation tool

By LabPulse.com staff writers

The grant will support platform development and artificial intelligence model creation to generate a comprehensive set of algorithms for malaria rapid diagnostic tests, the firm said.

April 18, 2023

Mexico IVD sales reach $794M: Kalorama Information

By Daniel Granderson

Immunoassays are Mexico’s leading IVD segment, followed by point-of-care and microbiology/molecular. Other POC, other molecular, and flow cytometry will be key segments to watch in coming years.

April 11, 2023

Pediatric reference intervals established for two common cardiovascular disease tests: AACC study

By LabPulse.com staff writers

Many pediatric hospitals have started to use high-sensitivity cardiac troponin and N-terminal pro B-type natriuretic peptide to detect levels of the proteins cTn I or T and NT-proBNP, respectively.

April 11, 2023

Serum protein in study predicted which patients might die without a liver transplant

By Elissa Wolfson

A retrospective analysis of blood samples and medical records from 270 patients hospitalized for acute liver failure analyzed serum concentrations of CPS1, a short-lived but abundant protein.

March 27, 2023

CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases

By LabPulse.com staff writers

The agreement with Beth Israel Deaconess Medical Center aims to solidify important technology for CND’s Syn-One Test, a skin-based test that aids the diagnosis of synucleinopathies, a family of neurodegenerative disorders.

March 22, 2023

Roche, Lilly partner on early diagnosis of Alzheimer's disease

By LabPulse.com staff writers

The firms are developing one of Roche's panels, which measures phosphorylated Tau (pTau) 181 protein and apolipoprotein (APOE) E4 in human blood plasma.

March 22, 2023

Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux

By LabPulse.com staff writers

The Santa Clara, CA-based company said it will use the funds to complete the development and commercialization of the Proxim Profile System, a portable and fully automated immunodiagnostic device.

March 21, 2023

Previous Page

Page 3 of 61

Next Page